Trials / Conditions / Metastatic Esophageal Adenocarcinoma

Metastatic Esophageal Adenocarcinoma

9 registered clinical trials studyying Metastatic Esophageal Adenocarcinoma — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenoc NCT06846346	UNICANCER	Phase 2
Recruiting	Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial NCT06203600	National Cancer Institute (NCI)	Phase 2 / Phase 3
Recruiting	A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People Wit NCT06251973	Memorial Sloan Kettering Cancer Center	Phase 2
Recruiting	Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Loca NCT05651594	Roswell Park Cancer Institute	Phase 2
Recruiting	mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastati NCT05677490	Alliance for Clinical Trials in Oncology	Phase 3
Active Not Recruiting	Abemaciclib Plus Ramucirumab for Esophageal/Gastroesophageal Junction Ca NCT04921904	Baylor Research Institute	Phase 1 / Phase 2
Active Not Recruiting	Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Eso NCT04460937	National Cancer Institute (NCI)	Phase 1
Active Not Recruiting	Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Ga NCT04248452	ECOG-ACRIN Cancer Research Group	Phase 3
Active Not Recruiting	Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal NCT01142388	National Cancer Institute (NCI)	Phase 2